Ovarian epithelial cancer stem cells.

Area of Science:

• Oncology
• Stem Cell Biology

Background:

• Epithelial ovarian cancer (EOC) is increasingly recognized as a disease driven by cancer stem cells (CSCs).
• Understanding the origins and early progression of EOC remains a significant challenge in oncology.
• Identifying and studying EOC-derived cancer stem cells (EOCSCs) is hindered by tumor heterogeneity and unknown normal ovarian stem cell populations.

Purpose of the Study:

• To review and evaluate current evidence for normal ovarian epithelial stem cells and EOCSCs.
• To highlight the need for improved laboratory methods for EOCSC isolation, identification, and enrichment.
• To discuss the origins of EOC, early pathogenic events, and the role of signaling pathways in EOCSC maintenance and function.

Main Methods:

• Literature review and critical evaluation of existing research on ovarian cancer stem cells.
• Analysis of evidence for candidate normal ovarian epithelial stem cells.
• Discussion of signaling pathways implicated in EOCSC biology and drug resistance.

Main Results:

• Evidence suggests the existence of both normal ovarian epithelial stem cells and EOCSCs, though definitive identification remains elusive.
• Tumor heterogeneity, unknown cell of origin, and lack of characterized normal counterparts complicate EOCSC research.
• Signaling pathways are critical regulators of EOCSC maintenance, function, and drug resistance, potentially differing across EOC subtypes.

Conclusions:

• Definitive laboratory approaches are urgently needed for the isolation and characterization of EOCSCs.
• Understanding EOCSCs is key to unraveling EOC pathogenesis and developing targeted therapies.
• EOCSCs play a significant role in therapeutic resistance, necessitating further investigation into their mechanisms and clinical relevance.